Manifold Partners’s Elevance Health ELV Stock Holding History

Manifold Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-20,509	Closed	-$2.04M	–	83
2014 Q1	$2.04M	Sell	20,509 -20,984	-51%	-$1.9M	1.35%	39
2013 Q4	$3.83M	Buy	41,493 +20,993	+102%	+$1.87M	2.48%	13
2013 Q3	$1.71M	Sell	20,500 -13,629	-40%	-$1.17M	1.1%	42
2013 Q2	$2.79M	Buy	+34,129	New	+$2.55M	1.97%	26

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Manifold Partners's ELV Position: Q2 2014 in Review

Manifold Partners sold out of Elevance Health (ELV) in Q2 2014, closing a stake of 20,509 shares — an estimated $2.04M sold.

Manifold Partners first reported a position in ELV in Q2 2013 and held it in 4 quarters. The position peaked at $3.83M in Q4 2013. 687 funds tracked by Wall St. Rank hold ELV as of Q2 2014.

Manifold Partners reported no remaining Elevance Health position as of Q2 2014 after selling out during the quarter.
Manifold Partners sold 20,509 Elevance Health shares in Q2 2014, an estimated $2.04M.
Manifold Partners first reported a position in Elevance Health in Q2 2013 and held it in 4 quarters.
Manifold Partners's Elevance Health position peaked at $3.83M in Q4 2013.
687 funds tracked by Wall St. Rank held Elevance Health as of Q2 2014.

Based on Manifold Partners's 13F filing for Q2 2014, filed 8 Aug 2014.